HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
Home » News » Express Scripts Jolts Markets with Drug List

Express Scripts Jolts Markets with Drug List

Top-three pharmacy benefit manager Express Scripts says it is excluding an extra 64 drugs from its list of preferred drugs, bringing the total to 159.

Radius Health’s shares surged 4.5 percent Monday after the announcement Lilly’s Forteo was getting the axe. The biotech also recently got the OK for its osteoporosis drug Tymlos, a direct rival to Forteo.

The updated formulary dealt a sizable blow to Synergy Pharmaceuticals after Express Scripts opted to leave off its constipation drug Trulance.

After climbing out of a 10 percent drop, Synergy’s shares closed down 4.4 percent Monday.

Click here to read a full report on BioPharma Dive.



You might also be interested in:

  • Venture firms warn R&D funding for new drugs will 'drop off a… 09/20/2021
  • Dems eye slimmed-down drug price deal to advance social… 10/28/2021
  • Politico Analysis: Health Data Breaches Accelerated in 2021 03/24/2022
  • HealthVerity Waterfall Strategy Uses Open and Closed… 09/09/2021
  • An extra 10,000 Britons are likely to die of cancer because of… 09/21/2021
  • Payers Facing Increased Scrutiny in Prescription Drug Pricing Debate 03/31/2022
  • Bayer, One Drop launch AI tool for heart disease prevention 11/04/2021

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Manager/Manager, RWE
  • Biostatistician/Statistical Analyst
  • Manager - Real World Evidence Engagement Lead (Remote- US)
  • Associate Director, Value & Access Strategy (Remote)
  • Manager, Value and Access Strategy (Remote- US)
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts